Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Impairment of investment in private companies	$ 30,321	$ 2,575	$ 4,488
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	1,200	(6,700)
Strategic investments	6,527	31,321
Series A Preferred Stock [Member] | Lacerta Therapeutics Inc [Member]
Schedule of Equity Method Investments [Line Items]
Impairment of investment in private companies	30,000
Fair Value, Inputs, Level 3 [Member]
Schedule of Equity Method Investments [Line Items]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	2,000	$ (6,700)
Biotechnology Company[ Member]
Schedule of Equity Method Investments [Line Items]
Strategic investments	5,500
Other Noncurrent Assets [Member]
Schedule of Equity Method Investments [Line Items]
Strategic investments	$ 5,500